MMP14和DDR2是转移性三阴性乳腺癌的潜在分子标记物
Rabeah Al-Temaimi1, Rasheed Ahmad2, Fahd Al-Mulla2
1Human Genetics Unit, Department of Pathology, College of Medicine, Kuwait University, P.O.Box 24923, 13110, Jabriya, Kuwait. Rabeah.altemaimi@ku.edu.kw.
Scientific reports
|July 2, 2025
概括
三重阴性乳腺癌 (TNBC) 是具有侵略性的. 研究人员确定了迪斯科伊丁域受体2 (DDR2) 和MMP14作为关键蛋白质标记物,可以帮助检测转移性TNBC,为新的免疫疗法铺平道路.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有高转移潜力的侵袭性癌症亚型.
- 目前的研究重点是确定有效的向治疗的独特分子标.
- 了解TNBC的分子格局对于开发新的治疗策略至关重要.
研究的目的:
- 在转移性和非转移性TNBC中研究矩阵金属蛋白酶 (MMP) 和迪斯科伊丁域受体2 (DDR2) 的蛋白质表达.
- 确定TNBC中免疫治疗的潜在分子标.
- 评估这些标记物在预测TNBC转移中的潜力.
主要方法:
- 利用TNBC组织微阵列进行蛋白质表达分析.
- 与瘤等级和转移状态相关联的MMPs (MMP1,MMP2,MMP3,MMP11,MMP12,MMP13,MMP14) 和DDR2的表达.
- 开发了多标志物模型,从非转移性TNBC预测转移性TNBC.
主要成果:
- MMP1表达与瘤等级相反相关,而MMP2,3,12和13表达与瘤等级直接相关.
- 转移性TNBC与DDR2,MMP11和MMP14的表达有显著的相关性.
- 一个3标记模型 (DDR2,MMP2,MMP14) 和一个全标记模型在分类转移性TNBC方面显示出显著的潜力.
结论:
- 建议MMP14和DDR2作为检测转移性TNBC的潜在分子标记物.
- 这些发现支持对针对MMP14和DDR2的针对性双重免疫疗法进行进一步的研究,用于TNBC治疗.
- 识别这些标志物可能会导致改善TNBC的诊断和治疗策略.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...


